SMO and meningioma: Two independent studies have identified TRAF7 (TNF receptor-associated factor 7), AKT1 (v-akt murine thymoma viral oncogene homolog 1), and SMO (Smoothened, frizzled family receptor) mutations as drivers of meningioma oncogenesis [11,12].